Stocks in Play: XORTX Therapeutics Inc.
XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal
XORTX Therapeutics Inc. (XRTX.V and NASDAQ: XRTX), a pharmaceutical company developing therapies to treat progressive kidney disease, on Monday announced a research paper showing for the first time th
XORTX Therapeutics Inc. Gets FDA Orphan Drug Designation For Oxypurinol For Treatment Of Autosomal Dominant Polycystic Kidney Disease
XORTX Therapeutics Inc. Gets FDA Orphan Drug Designation For Oxypurinol For Treatment Of Autosomal Dominant Polycystic Kidney Disease
Xortx Therapeutics Inc Filed For Mixed Shelf Of Up To $50M
Xortx Therapeutics Inc Filed For Mixed Shelf Of Up To $50M
Xortx Stock Surges ~60% as Potential Kidney Disease Drug Shows Promise in Early Stage Study
Xortx Stock Soars 40% as Kidney Disease Drug Shows Promise in Bridging Study
Xortx Therapeutics (NASDAQ:XRTX) said its proprietary formulation of oxypurinol showed a substantial increase in oral bioavailability provided with food compared to the fasted state in a pharmacokinet
Press Release: XORTX Therapeutics Announces Annual and Special Meeting of Shareholders
XORTX Therapeutics Announces Annual and Special Meeting of Shareholders CALGARY, Alberta, Nov. 23, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (TSXV: XRTX | NASD
XORTX Therapeutics Announces Partial Exercise of Over-Allotment Option Pursuant to US Public Offering
CALGARY, Alberta, Nov. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (TSXV: XRTX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innova
XORTX Therapeutics Clarifies Halt of Trading in Canada and Timing for Commencement of Trading on TSX Venture Exchange
CALGARY, Alberta, Nov. 04, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (TSXV: XRTX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innova
XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange
CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovati
Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49. The U.S. has the highest num
XORTX Therapeutics Shares Drop 30% Premarket After Public Offering Prices
By Chris Wack XORTX Therapeutics Inc. shares were down 30% to $3.35 in premarket trading Wednesday after the company said it priced an underwritten public offering of 2.9 million units, with
Xortx Therapeutics announces Nasdaq listing; prices $12M public offering
XORTX Therapeutics (OTCQB:XRTXF) has priced its public offering of 2,906,000 units, with each unit consisting of one common share, and one warrant to purchase one common share at $4.13/unit, for gros
BMW CEO predicts that chip supply will remain tight in the next 6-12 months
Oliver Zipse, BMW's chief executive, said on Monday that supply chain tensions were expected to continue into 2022, dashing hopes that a critical shortage of key semiconductors would end soon. "I expect the general tension in the supply chain to continue over the next six to 12 months," he said at the IAA auto show in Munich. Zipse, like other auto industry executives, is struggling with a drop in production caused by a shortage of semiconductors. But he said he saw no problem in the long run, adding that the auto industry was a very attractive customer for chipmakers.
Alphabet Inc-CL C announced the dissolution of the health department and the departure of the head of Google Health on September 1st.
Sina Science and Technology News Beijing time on the evening of August 20, it is reported that Alphabet Inc-CL C will dissolve his health department Google Health, the department director David Feinberg (David Feinberg) will leave on September 1. According to an internal memo, Google Health's projects and teams will be distributed to different departments of Alphabet Inc-CL C. Meanwhile, electronic medical records giant Cerner announced today that Feinberg will join the company as CEO and president. Google Heath was founded in 2018 by highly respected doctors.
600,000 people died in the pandemic, and the life expectancy of Americans was shortened by a year and a half
As hundreds of thousands of Americans died as a result of the COVID-19 pandemic, the average life expectancy of Americans was shortened by 1.5 years to 77.3 years in 2020, the biggest annual decline since 1943. Estimates released by the US Centers for Disease Control and Prevention (CDC) show that the pandemic's disproportionate deaths in communities of color have also widened the existing gap in life expectancy between white and black Americans. This number represents an extremely grim record of an ongoing disaster. The first year of the pandemic hit Americans' life expectancy more than the Vietnam War, the AIDS crisis, or “despair”
Inflation anxiety is getting hotter, US bond traders stay away from treasury bond futures
After the CPI data was released, the number of open contracts on 10-year US Treasury bond futures declined, and the proportion of J.P. Morgan's US Treasury bond clients held neutral positions increased, and growing concerns about inflation are causing US debt investors to retreat from treasury bond futures. After the data showed that the CPI increase in June exceeded expectations, US bond futures accelerated their decline on the same day, further exacerbating the selling pressure on the bond market. The number of open 10-year treasury bond futures contracts due in September 2021 fell by 1.3% to 4.15 million, the lowest in the history of this contract. The reduction of 53,000 contracts is equivalent to 5 billion US dollars of 10-year treasury bonds. Currently, there is 1
No Data